These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1365 related articles for article (PubMed ID: 14696433)

  • 41. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver.
    Salman HS; Cynamon J; Jagust M; Bakal C; Rozenblit A; Kaleya R; Negassa A; Wadler S
    Clin Colorectal Cancer; 2002 Nov; 2(3):173-9. PubMed ID: 12482334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized study.
    Fiorentini G; Cantore M; Rossi S; Vaira M; Tumolo S; Dentico P; Mambrini A; Bernardeschi P; Turrisi G; Giovanis P; Guadagni S; Valori V; De Simone M
    In Vivo; 2006; 20(6A):707-9. PubMed ID: 17203750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Arterial infusion chemotherapy of 5-FU and leucovorin for patients with liver metastases from colorectal cancer].
    Yamamura T; Hanai A; Oikawa H; Matsuzaki H; Kikuchi K; Akaishi O; Seo K; Ozasa T; Katayama K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1516-9. PubMed ID: 8373209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Preliminary clinical evaluation of low-dose cisplatin and continuous infusion of 5-FU (LFP) chemotherapy after weekly high-dose 5-FU therapy for the treatment of liver metastases from colorectal cancer].
    Itoh S; Morita S; Ohnishi T; Tsuji A; Takamatsu M; Horimi T
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1167-70. PubMed ID: 12145997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic arterial infusion chemotherapy through a port-catheter system as preoperative initial therapy in patients with advanced liver dysfunction due to synchronous and unresectable liver metastases from colorectal cancer.
    Iguchi T; Arai Y; Inaba Y; Yamaura H; Sato Y; Miyazaki M; Shimamoto H
    Cardiovasc Intervent Radiol; 2008; 31(1):86-90. PubMed ID: 17926088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
    Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
    Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
    Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases.
    Heinrich S; Petrowsky H; Schwinnen I; Staib-Sebler E; Gog C; El-Ganainy A; Gutt C; Müller HH; Lorenz M
    Surgery; 2003 Jan; 133(1):40-8. PubMed ID: 12563236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The efficacy and limitation of hepatic arterial infusion chemotherapy for colorectal liver metastases].
    Tono T; Ohzato H; Hasuike Y; Watanabe H; Hayashi S; Fukunaga M; Aihara T; Kan K; Imamoto H; Yamazaki K; Kikkawa N; Takatsuka Y
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1741-6. PubMed ID: 10560385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of liver metastases from colorectal cancer.
    Isenberg J; Fischbach R; Krüger I; Keller HW
    Anticancer Res; 1996; 16(3A):1291-5. PubMed ID: 8702252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Curative and palliative aspects of regional chemotherapy in combination with surgery.
    Müller H; Hilger R
    Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The 5-fluorouracil hepato-arterial infusion with oral UFT therapy for the hepatic and extra hepatic metastases of colorectal cancer].
    Maruyama S; Maruyama M; Kato K; Koide A; Ohbu M; Hasegawa K; Takashima I; Ebuchi M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1743-5. PubMed ID: 15553701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Switching to direct intrahepatic arterial infusion of 5-FU after a progression of liver metastases from colorectal carcinoma treated with systemic infusion of FOLFOX].
    Kikuoka S; Miura T; Takeuchi I; Miura T; Akamatsu N; Ishida F; Ozawa F; Moriguchi M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2036-8. PubMed ID: 20037315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases.
    Okuno K; Shigeoka H; Lee YS; Son E; Kayama H; Nakai T; Koh K; Yasutomi M
    Hepatogastroenterology; 1996; 43(9):688-91. PubMed ID: 8799416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
    Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
    Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical outcome of intra-hepatic arterial infusion therapy for multiple liver metastases from colorectal cancer].
    Okamoto N; Maruta M; Maeda K; Sato H; Takizawa K; Masumori K; Aoyama H; Kato R
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):501-4. PubMed ID: 12722681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial.
    Sadahiro S; Suzuki T; Ishikawa K; Yasuda S; Tajima T; Makuuchi H; Saitoh T; Murayama C
    Cancer; 2004 Feb; 100(3):590-7. PubMed ID: 14745877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Weekly hepatic arterial infusion of high-dose 5-FU for liver metastases from colorectal cancer].
    Motohara T; Ogawa K; Morita S
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2335-9. PubMed ID: 8259847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
    Samaras P; Breitenstein S; Haile SR; Stenner-Liewen F; Heinrich S; Feilchenfeldt J; Renner C; Knuth A; Pestalozzi BC; Clavien PA
    Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Combined therapy of metastatic liver neoplasms: intrahepatic chemoembolization and systemic chemotherapy].
    Pajkos G; Szentpétery L; Kristó K; Izsó J
    Orv Hetil; 1998 Apr; 139(17):1013-7. PubMed ID: 9608765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.